Darmowa dostawa z usługą Inpost oraz Orlen od 299.00 zł
InPost 13.99 DPD 25.99 Paczkomat 13.99 Poczta Polska 18.99 ORLEN Paczka 10.99

Gene and Cell Therapies for Beta-Globinopathies

Język AngielskiAngielski
Książka Miękka
Książka Gene and Cell Therapies for Beta-Globinopathies Punam Malik
Kod Libristo: 21958588
Wydawnictwo Springer-Verlag New York Inc., sierpień 2018
Hemoglobin defects, specifically sickle cell disease & thalassemia, combined, constitute the most co... Cały opis
? points 387 b
658.34
Dostępna u dostawcy Wysyłamy za 6-8 dni

30 dni na zwrot towaru

Hemoglobin defects, specifically sickle cell disease & thalassemia, combined, constitute the most common monogenic disorders in the world. In fact, nearly 2% of the world's population carries a globin gene mutation. The transfer of the corrective globin gene through the HSC compartment by allogeneic HSC transplantation (HSCT) has already proven curative in both SCD and thalassemia patients, and provides the proof of concept that genetic manipulation of the defective organ might be equally therapeutic. However, procedural toxicities and the requirement of an HLA-matched sibling donor limit this approach to a fraction of affected individuals. The editors review the progress & the state of the field in HSCT for hemoglobinopathies & shed light on the major changes expected in the next decade. Although allogeneic HSCT is a curative option, it is limited by the availability of matched donors, which are often available only to 15-20% of patients. An alternative to allogeneic HSCT is genetic correction of autologous HSCs, to overcome donor availability & immune side effects. This Book reviews the progress made on additive gene therapy approaches & the current state of the field. Finally, targeted genetic correction is emerging as a novel therapeutic strategy in the hemoglobinopathies. Although ideal, the inefficiency of targeted correction was rate limiting for translation of this technology to the clinic. With advancements in zinc finger nucleases and TALE endonuclease mediated targeted correction, correction frequencies in hematopoietic stem cells is now reaching levels that may become clinically relevant. Furthermore, the ability to generate autologous embryonic stem cell like cells from primary somatic cells (skin fibroblasts or hematopoietic cells) of the affected individual has allowed for the potential application of genetic correction strategies.This Book reviews upcoming genetic strategies to reactivate fetal hemoglobin production and research advances.

Informacje o książce

Pełna nazwa Gene and Cell Therapies for Beta-Globinopathies
Język Angielski
Oprawa Książka - Miękka
Data wydania 2018
Liczba stron 248
EAN 9781493984466
ISBN 9781493984466
Kod Libristo 21958588
Waga 403
Wymiary 155 x 235 x 15
Podaruj tę książkę jeszcze dziś
To łatwe
1 Dodaj książkę do koszyka i wybierz „dostarczyć jako prezent” 2 W odpowiedzi wyślemy Ci bon 3 Książka dotrze na adres obdarowanego

Logowanie

Zaloguj się do swojego konta. Nie masz jeszcze konta Libristo? Utwórz je teraz!

 
obowiązkowe
obowiązkowe

Nie masz konta? Zyskaj korzyści konta Libristo!

Dzięki kontu Libristo będziesz mieć wszystko pod kontrolą.

Utwórz konto Libristo